European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage

International Journal of Stroke

Volumn 9, Issue 7, 2014, Pages 840-855

  Steiner, Thorsten ^a,b   Al Shahi Salman, Rustam ^c   Beer, Ronnie ^d   Christensen, Hanne ^e   Cordonnier, Charlotte ^f   Csiba, Laszlo ^g   Forsting, Michael ^h   Harnof, Sagi ⁱ   Klijn, Catharina J M ^j   Krieger, Derk ^e   Mendelow, A David ^k   Molina, Carlos ^l   Montaner, Joan ^l   Overgaard, Karsten ^e   Petersson, Jesper ^m   Roine, Risto O ⁿ   Schmutzhard, Erich ^d   Schwerdtfeger, Karsten ^o   Stapf, Christian ^p   Tatlisumak, Turgut ^q   Thomas, Brenda M ^c   Toni, Danilo ^r   Unterberg, Andreas ^s   Wagner, Markus ^t   more..

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIV LILLE   (France)

^g UNIVERSITY OF DEBRECEN   (Hungary)

^h UNIVERSITY HOSPITAL ESSEN   (Germany)

ⁱ SHEBA MEDICAL CENTER   (Israel)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k NEWCASTLE UNIVERSITY   (United Kingdom)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m LUND UNIVERSITY HOSPITAL   (Sweden)

ⁿ TURKU UNIVERSITY HOSPITAL   (Finland)

^o SAARLAND UNIVERSITY   (Germany)

^p HÔPITAL LARIBOISIÈRE   (France)

^q HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^r SAPIENZA UNIVERSITY OF ROME   (Italy)

^s UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^t Stiftung Deutsche Schlaganfall Hilfe   (Germany)

more..

Author keywords

Anticoagulation; Antiepileptic treatment; Antihypertensive treatment; Intracranial hemorrhage; Intracranial pressure; Management

Indexed keywords

APIXABAN; DABIGATRAN; EDOXABAN; ENOXAPARIN; RIVAROXABAN; VALPROIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPRESSION STOCKING; CONTROLLED STUDY; EUROPEAN; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIST; SECONDARY PREVENTION; SEIZURE; SYSTOLIC BLOOD PRESSURE; VENTRICULOSTOMY CATHETER; CEREBRAL HEMORRHAGE; DISEASE MANAGEMENT;

CEREBRAL HEMORRHAGE; DISEASE MANAGEMENT; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907876500     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12309     Document Type: Article

References (154)

1. Feigin VL, Forouzanfar MH, Krishnamurthi R etal. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383:245-254.
2. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8:355-369.
3. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9:167-176.
4. Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2014; 85:660-667.
5. Morgenstern LB, Hemphill JC III, Anderson C etal. Guidelines for the management of spontaneous intracerebral hemorrhage. a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41:2108-2129.
6. Steiner T, Petersson J, Al-Shahi Salman R etal. European research priorities for intracerebral haemorrhage. Cerebrovasc Dis 2011; 32:409-419.
7. Steiner T, Kaste M, Forsting M etal. Recommendations for the management of intracranial haemorrhage - part 1: spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis 2006; 22:294-316.
8. GRADE Working Group. Overview of GRADE approach. 2011. Available at: http://www.gradeworkinggroup.org/index.htm (accessed June 2011).
9. Centre for Evidence-Based Medicine. Levels of evidence. 2011. Available at: http://www.cebm.net/index.aspx?o=1001 (accessed December 2011).
10. Cochrane Stroke Group. About the Cochrane Collaboration [Cochrane Review Groups (CRGs)]. Available at http://onlinelibrary.wiley.com/book/10.1002/14651858/homepage/crglist.html
11. Leone MA, Brainin M, Boon P etal. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012. Eur J Neurol 2013; 20:410-419.
12. Guyatt GH, Oxman AD, Vist GE etal. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-926.
13. Pocock SJ, Ware JH. Translating statistical findings into plain English. Lancet 2009; 373:1926-1928.
14. Andrews J, Guyatt G, Oxman AD etal. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013; 66:719-725.
15. Langhorne P, Fearon P, Ronning OM etal. Stroke unit care benefits patients with intracerebral hemorrhage: systematic review and meta-analysis. Stroke 2013; 44:3044-3049.
16. Kurtz P, Fitts V, Sumer Z etal. How does care differ for neurological patients admitted to a neurocritical care unit versus a general ICU? Neurocrit Care 2011; 15:477-480.
17. Kallmunzer B, Breuer L, Kahl N etal. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors - a systematic, prospective analysis. Stroke 2012; 43:2892-2897.
18. Knopf L, Staff I, Gomes J, McCullough L. Impact of a neurointensivist on outcomes in critically ill stroke patients. Neurocrit Care 2012; 16:63-71.
19. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001; 29:635-640.
20. Terent A, Asplund K, Farahmand B etal. Stroke unit care revisited: who benefits the most? A cohort study of 105, 043 patients in Riks-Stroke, the Swedish Stroke Register. J Neurol Neurosurg Psychiatry 2009; 80:881-887.
21. Candelise L, Gattinoni M, Bersano A, Micieli G, Sterzi R, Morabito A. Stroke-unit care for acute stroke patients: an observational follow-up study. Lancet 2007; 369:299-305.
22. Evans A, Perez I, Harraf F etal. Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet 2001; 358:1586-1592.
23. Anderson CS, Heeley E, Huang Y etal. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368:2355-2365.
24. Anderson CS, Huang Y, Wang JG etal. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7:391-399.
25. Qureshi AI, ATACH Investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010; 38:637-648.
26. Anderson CS, Huang Y, Arima H etal. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010; 41:307-312.
27. Arima H, Anderson CS, Wang JG etal. Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. Hypertension 2010; 56:852-858.
28. Qureshi AI, Palesch YY, Martin R etal. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage Study. Arch Neurol 2010; 67:570-576.
29. Koch S, Romano JG, Forteza AM, Otero CM, Rabinstein AA. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care 2008; 8:316-321.
30. Xu MY. Effect of blood pressure lowering strategy on the enlargement of hematoma and clinical outcome in patients with acute intracerebral haemorrhage. Chin J Cerebrovasc Dis 2011; 8:23-27.
31. Sandset EC, Bath PM, Boysen G etal. The Angiotensin-Receptor Blocker Candesartan for Treatment of Acute Stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; 377:741-750.
32. Potter JF, Robinson TG, Ford GA etal. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009; 8:48-56.
33. Al-Shahi Salman R. Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev 2009; (4):CD005951.
34. Yuan ZH, Jiang JK, Huang WD, Pan J, Zhu JY, Wang JZ. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia. J Clin Neurosci 2010; 17:685-693.
35. Yank V, Tuohy CV, Logan AC etal. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011; 154:529-540.
36. Diringer MN, Skolnick BE, Mayer SA etal. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke 2010; 41:48-53.
37. Li X, Wang YQ, Li W. Intervention study on recombinant activated factor VIIa in depressing early hematoma extensions of cerebral hemorrhage. Chin J New Drugs 2012; 21:161-163.
38. Imberti R, Pietrobono L, Klersy C, Gamba G, Iotti G, Cornara G. Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. Minerva Anestesiol 2012; 78:168-175.
39. Sprigg N, Renton CJ, Dineen RA, Kwong Y, Bath PM. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). J Stroke Cerebrovasc Dis 2014; 23:1312-1318.
40. Campbell PG, Sen A, Yadla S, Jabbour P, Jallo J. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. World Neurosurg 2010; 74:279-285.
41. Joseph B, Pandit V, Sadoun M etal. A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage. J Trauma Acute Care Surg 2013; 75:990-994.
42. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999; 45:1113-1118, discussion 8-9.
43. Kerebel D, Joly LM, Honnart D etal. A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal. Crit Care 2013; 17:R4.
44. Bershad EM, Suarez JI. Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature. Neurocrit Care 2010; 12:403-413.
45. Majeed A, Kim YK, Roberts RS, Holmstrom M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 2010; 41:2860-2866.
46. Steiner T, Bohm M, Dichgans M etal. Recommendations for the emergency management of complications associated with new direct oral anticoagulants (DOAC) apixaban, dabigatran, and rivaroxaban. Clin Res Cardiol 2013; 102:399-412.
47. Mendelow AD, Gregson BA, Fernandes HM etal. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365:387-397.
48. Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 2013; 382:397-408.
49. Gregson BA, Broderick JP, Auer LM etal. Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke 2012; 43:1496-1504.
50. Mould WA, Carhuapoma JR, Muschelli J etal. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke 2013; 44:627-634.
51. Chen CC, Liu CL, Tung YN etal. Endoscopic surgery for intraventricular hemorrhage (IVH) caused by thalamic hemorrhage: comparisons of endoscopic surgery and external ventricular drainage (EVD) surgery. World Neurosurg 2011; 75:264-268.
52. Staykov D, Huttner HB, Struffert T etal. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke 2009; 40:3275-3280.
53. Hanley DF. Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke 2009; 40:1533-1538.
54. Newell DW, Shah MM, Wilcox R etal. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis. J Neurosurg 2011; 115:592-601.
55. Hinson HE, Hanley DF, Ziai WC. Management of intraventricular hemorrhage. Curr Neurol Neurosci Rep 2010; 10:73-82.
56. Gubucz I, Kakuk I, Major O etal. Effectiveness and safety of intraventricular fibrinolysis in secondary intraventricular hemorrhages (a prospective, randomized study). Orv Hetil 2004; 145:1609-1615.
57. Tamaki T, Kitamura T, Node Y, Teramoto A. Paramedian suboccipital mini-craniectomy for evacuation of spontaneous cerebellar hemorrhage. Neurol Med Chir (Tokyo) 2004; 44:578-582, discussion 83.
58. Dammann P, Asgari S, Bassiouni H etal. Spontaneous cerebellar hemorrhage-experience with 57 surgically treated patients and review of the literature. Neurosurg Rev 2011; 34:77-86.
59. Kirollos RW, Tyagi AK, Ross SA, van Hille PT, Marks PV. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery 2001; 49:1378-1386, discussion 86-7.
60. Kobayashi S, Sato A, Kageyama Y, Nakamura H, Watanabe Y, Yamaura A. Treatment of hypertensive cerebellar hemorrhage - surgical or conservative management? Neurosurgery 1994; 34:246-250, discussion 50-1.
61. Papacocea A, Papacocea T, Danaila L, Ion D, Badarau A, Papacocea R. Primary intracerebellar hematomas: surgical indications, prognosis. Chirurgia (Bucur) 2010; 105:805-807.
62. Krylov VV, Dash'ian VG, Murashko AA, Burov SA. Diagnostic and treatment of hypertensive cerebellar hematomas. Zh Nevrol Psikhiatr Im S S Korsakova 2009; 109:24-29.
63. Auer LM, Auer T, Sayama I. Indications for surgical treatment of cerebellar haemorrhage and infarction. Acta Neurochir (Wien) 1986; 79:74-79.
64. Dolderer S, Kallenberg K, Aschoff A, Schwab S, Schwarz S. Long-term outcome after spontaneous cerebellar haemorrhage. Eur Neurol 2004; 52:112-119.
65. Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res 1984; 6:145-151.
66. Mathew P, Teasdale G, Bannan A, Oluoch-Olunya D. Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry 1995; 59:287-292.
67. Ziai WC, Melnychuk E, Thompson CB, Awad I, Lane K, Hanley DF. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med 2012; 40:1601-1608.
68. Sadaka F, Kasal J, Lakshmanan R, Palagiri A. Placement of intracranial pressure monitors by neurointensivists: case series and a systematic review. Brain Inj 2013; 27:600-604.
69. Dizdarevic K, Hamdan A, Omerhodzic I, Kominlija-Smajic E. Modified Lund concept versus cerebral perfusion pressure-targeted therapy: a randomised controlled study in patients with secondary brain ischaemia. Clin Neurol Neurosurg 2012; 114:142-148.
70. Stein DM, Hu PF, Brenner M etal. Brief episodes of intracranial hypertension and cerebral hypoperfusion are associated with poor functional outcome after severe traumatic brain injury. J Trauma 2011; 71:364-373, discussion 73-4.
71. Santos E, Diedler J, Sykora M etal. Low-frequency sampling for PRx calculation does not reduce prognostication and produces similar CPPopt in intracerebral haemorrhage patients. Acta Neurochir (Wien) 2011; 153:2189-2195.
72. Eide PK, Bentsen G, Sorteberg AG, Marthinsen PB, Stubhaug A, Sorteberg W. A randomized and blinded single-center trial comparing the effect of intracranial pressure and intracranial pressure wave amplitude-guided intensive care management on early clinical state and 12-month outcome in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2011; 69:1105-1115.
73. Yu YL, Kumana CR, Lauder IJ etal. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo controlled, randomized trial. Stroke 1992; 23:967-971.
74. Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci 2005; 234:41-45.
75. Wagner I, Hauer EM, Staykov D etal. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke 2011; 42:1540-1545.
76. Kollmar R, Staykov D, Dorfler A, Schellinger PD, Schwab S, Bardutzky J. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke 2010; 41:1684-1689.
77. Shimamura N, Munakata A, Naraoka M, Nakano T, Ohkuma H. Decompressive hemi-craniectomy is not necessary to rescue supratentorial hypertensive intracerebral hemorrhage patients: consecutive single-center experience. Acta Neurochir Suppl 2011; 111:415-419.
78. Ma L, Liu WG, Sheng HS, Fan J, Hu WW, Chen JS. Decompressive craniectomy in addition to hematoma evacuation improves mortality of patients with spontaneous basal ganglia hemorrhage. J Stroke Cerebrovasc Dis 2010; 19:294-298.
79. Dierssen G, Carda R, Coca JM. The influence of large decompressive craniectomy on the outcome of surgical treatment in spontaneous intracerebral haematomas. Acta Neurochir (Wien) 1983; 69:53-60.
80. Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 2008; 39:3029-3035.
81. den Hertog HM, van der Worp HB, van Gemert HM etal. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 2009; 8:434-440.
82. Broessner G, Beer R, Lackner P etal. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke 2009; 40:e657-665.
83. Diringer MN. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 2004; 32:559-564.
84. Zhang XM, Li XL, Tang SH, Liu QC. Effect of head hypothermia on serum inflammatory cytokines levels in patients with hypertensive intracerebral hemorrhage. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006; 18:294-296.
85. Dohi K, Jimbo H, Ikeda Y etal. Pharmacological brain cooling with indomethacin in acute hemorrhagic stroke: antiinflammatory cytokines and antioxidative effects. Acta Neurochir Suppl 2006; 96:57-60.
86. Huang H, Liu F, Zhan R. Treatment of hypertensive cerebral hemorrhage by early-used mild hypothermia. Zhejiang Med J 2003; 25:326-327.
87. Feng H, Shi D, Wang D etal. Effect of local mild hypothermia on treatment of acute intracerebral hemorrhage, a clinical study. Zhonghua Yi Xue Za Zhi 2002; 82:1622-1624.
88. Xu L, Li X, Zhang X. Clinical efficacy of head mild hypothermia in treatment of hypertensive intracerebral haemorrhage. Chin J Geriatr Cardiovasc Cerebrovasc Dis 2002; 4:327-329.
89. Penner M, Silasi G, Wowk S, Warkentin L, Colbourne F. Brief hyperthermia does not worsen outcome after striatal hemorrhage in rats. Curr Neurovasc Res 2011; 8:35-43.
90. Abdullah JM, Husin A. Intravascular hypothermia for acute hemorrhagic stroke: a pilot study. Acta Neurochir Suppl 2011; 111:421-424.
91. Poli S, Purrucker J, Priglinger M etal. Induction of cooling with a passive head and neck cooling device: effects on brain temperature after stroke. Stroke 2013; 44:708-713.
92. Kallmunzer B, Krause C, Pauli E etal. Standardized antipyretic treatment in stroke: a pilot study. Cerebrovasc Dis 2011; 31:382-389.
93. Lord AS, Karinja S, Carpenter A etal. Therapeutic temperature modulation for fever after intracranial hemorrhage: a cas-control study. Neurocrit Care 2012; 17:S141.
94. Govan L, Langhorne P, Weir CJ. Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care?: further analysis of a systematic review. Stroke 2007; 38:2536-2540.
95. Middleton S, McElduff P, Ward J etal. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet 2011; 378:1699-1706.
96. de Ridder IR, de Jong FJ, den Hertog HM etal. Paracetamol (Acetaminophen) in Stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 degrees C or above. Int J Stroke 2013.
97. Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PA. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2010; (8):CD001922.
98. Dennis M, Sandercock PA, Reid J etal. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 2009; 373:1958-1965.
99. CLOTS Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med 2010; 153:553-562.
100. Lacut K, Bressollette L, Le Gal G etal. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005; 65:865-869.
101. Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet 2013; 382:516-524.
102. Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1991; 54:466-467.
103. Orken DN, Kenangil G, Ozkurt H etal. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist 2009; 15:329-331.
104. Wasay M, Khan S, Zaki KS etal. A non-randomized study of safety and efficacy of heparin for DVT prophylaxis in intracerebral haemorrhage. J Pak Med Assoc 2008; 58:362-364.
105. Wu TC, Kasam M, Harun N etal. Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke 2011; 42:705-709.
106. Lodder J, van Raak L, Hilton A, Hardy E, Kessels A. Diazepam to improve acute stroke outcome: results of the early GABA-ergic activation study in stroke trial. a randomized double-blind placebo-controlled trial. Cerebrovasc Dis 2006; 21:120-127.
107. Gilad R, Boaz M, Dabby R, Sadeh M, Lampl Y. Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment? Epilepsy Res 2011; 95:227-231.
108. Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002; 43:1175-1180.
109. Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag 2008; 4:715-720.
110. Bladin CF, Alexandrov AV, Bellavance A etal. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57:1617-1622.
111. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke 1997; 28:1590-1594.
112. Giroud M, Gras P, Fayolle H, Andre N, Soichot P, Dumas R. Early seizures after acute stroke: a study of 1, 640 cases. Epilepsia 1994; 35:959-964.
113. Burneo JG, Fang J, Saposnik G. Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study. Eur J Neurol 2010; 17:52-58.
114. Garrett MC, Komotar RJ, Starke RM, Merkow MB, Otten ML, Connolly ES. Predictors of seizure onset after intracerebral hemorrhage and the role of long-term antiepileptic therapy. J Crit Care 2009; 24:335-339.
115. De Herdt V, Dumont F, Henon H etal. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 2011; 77:1794-1800.
116. Messe SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care 2009; 11:38-44.
117. Naidech AM, Garg RK, Liebling S etal. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke 2009; 40:3810-3815.
118. Desai P, Prasad K. Dexamethasone is not necessarily unsafe in primary supratentorial intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1998; 65:799-800.
119. Hooshmand H, Quinn JC, Houff SA. Cerebrospinal fluid pressure changes with chemotherapy for intracerebral hemorrhage. Neurology 1972; 22:56-61.
120. Ogun SA, Odusote KA. Effectiveness of high dose dexamethasone in the treatment of acute stroke. West Afr J Med 2001; 20:1-6.
121. Poungvarin N, Bhoopat W, Viriyavejakul A etal. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987; 316:1229-1233.
122. Tellez H, Bauer RB. Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke 1973; 4:541-546.
123. Feigin VL, Anderson NE, Rinkel GJE, Algra A, van Gjn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid hemorrhage and primary intracerebral hemorrhage. Cochrane Database of Systematic Reviews 2005, art. no.: CD004583.
124. Sharafadinzadeh N, Baghebanian SM, Pipelzadeh M, Maravej AAA, Ghanavati P. Effects of dexamethasone in primary intracerebral hemorrhage in the south west of Iran. Pak J Med Sci 2008; 24:502-505.
125. Broderick J, Brott T, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24:987-993.
126. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32:891-897.
127. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 1998; 29:1352-1357.
128. Becker KJ, Baxter AB, Cohen WA etal. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 2001; 56:766-772.
129. Creutzfeldt CJ, Becker KJ, Weinstein JR etal. Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med 2011; 39:158-162.
130. Zahuranec DB, Brown DL, Lisabeth LD etal. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology 2007; 68:1651-1657.
131. Rydvall A, Lynoe N. Withholding and withdrawing life-sustaining treatment: a comparative study of the ethical reasoning of physicians and the general public. Crit Care 2008; 12:R13.
132. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
133. Chapman N, Huxley R, Anderson C etal. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke 2004; 35:116-121.
134. Arima H, Tzourio C, Anderson C etal. Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS Trial. Stroke 2010; 41:394-396.
135. Arima H, Huang Y, Wang JG etal. Earlier blood pressure-lowering and greater attenuation of hematoma growth in acute intracerebral hemorrhage: INTERACT pilot phase. Stroke 2012; 43:2236-2238.
136. Perry HM Jr, Davis BR, Price TR etal. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284:465-471.
137. Chambers JA, O'Carroll RE, Hamilton B etal. Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol 2011; 16:592-609.
138. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119:3028-3035.
139. Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007; 6:487-493.
140. Thompson BB, Bejot Y, Caso V etal. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 2010; 75:1333-1342.
141. Chong BH, Chan KH, Pong V etal. Use of aspirin in Chinese after recovery from primary intracranial haemorrhage. Thromb Haemost 2012; 107:241-247.
142. Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke 2010; 41:2606-2611.
143. Biffi A, Halpin A, Towfighi A etal. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010; 75:693-698.
144. Poli D, Antonucci E, Testa S etal. Rate of recurrent cerebral bleeding in patients with a first episode of cerebral hemorrhage and who need vitamin K antagonists treatment: results of a collaborative study. Paper presented at XXII Congreso Nazionale SISET, Vicenza, Italy, 2012. Available at: http://www.bloodtransfusion.it.
145. Chandra D, Gupta A, Grover V, Kumar GV. When should you restart anticoagulation in patients who suffer an intracranial bleed who also have a prosthetic valve? Interact Cardiovasc Thorac Surg 2013; 16:520-524.
146. Claassen DO, Kazemi N, Zubkov AY, Wijdicks EF, Rabinstein AA. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol 2008; 65:1313-1318.
147. Masotti L, Godoy DA, Napoli MD, Rabinstein AA, Paciaroni M, Ageno W. Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: what do we know about risks and benefits? Clin Appl Thromb Hemost 2012; 18:393-402.
148. Yung D, Kapral MK, Asllani E, Fang J, Lee DS; Investigators of the Registry of the Canadian Stroke Network. Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol 2012; 28:33-39.
149. Aguilar MI, Hart RG, Kase CS etal. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007; 82:82-92.
150. Reddy VY, Doshi SK, Sievert H etal. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 2013; 127:720-729.
151. Horstmann S, Zugck C, Krumsdorf U etal. Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage. Neurology 2014; 82:135-138.
152. Mayer SA, Davis SM, Skolnick BE etal. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke 2009; 3:833-840.
153. Piriyawat P, Morgenstern LB, Yawn D, Hall CE, Grotta JC. Treatment of acute intracerebral hemorrhage with e-aminocaproic acid - a pilot study. Neurocrit Care 2004; 1:47-51.
154. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007; 334:349-351.